MNR Product And Science Advisory LLC

MNR Product And Science Advisory LLC, a Delaware-based sole proprietorship, provides expert witness and litigative case support services to the Department of Justice and Department of Health and Human Services as a prime contractor on a full-and-open, non-set-aside basis. The vendor operates entirely as a prime (100% of recent awards) with no subcontract activity, competing on time-and-materials purchase orders and blanket purchase agreements under PSC Support—Professional: Expert Witness.

The vendor's customer base is heavily concentrated by dollar value but split by volume. The Department of Health and Human Services anchors 96% of combined potential value through a single $7.5 million BPA with the Health Resources and Services Administration established August 31, 2026, supporting the Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP) with a completion date of August 30, 2031. The Department of Justice Civil Division accounts for 13 of 14 recent awards but represents only $259 thousand in combined potential value—thirteen time-and-materials purchase orders issued between February and September 2026, each carrying ceiling values between $14,991 and $26,241 and extending through 2029. Work is performed in Delaware and Ohio under time-and-materials pricing across both customer relationships.

Activity launched in 2026 with fourteen awards spanning two customer agencies. All fourteen awards are prime positions carrying no small business set-aside designations. The HHS BPA ceiling of $7.5 million dominates the portfolio's dollar potential, though actual obligation across all awards stands at $236 thousand (3% of combined potential value), indicating early-stage drawdown. The DOJ Civil Division orders, issued monthly from February through September 2026, provide recurring volume but at small individual transaction sizes; all thirteen orders carry ultimate completion dates between February 2029 and September 2029, creating recompete exposure across the full DOJ workload in that window. The HHS BPA extends through August 2031, providing longer-term revenue stability, though no task orders or purchase orders against it appear in the source beyond the initial BPA establishment. The vendor holds no positions on government-wide vehicles, GSA Schedules, or multi-agency IDIQs; work flows through direct agency purchase orders and single-award mechanisms.